The decarboxylation of amino acids is an cssential step in the biosynthesis of biogenic amines; the enzyme aromatic Lamino acid decarboxylase (AAAD; EC 4.1.1.28) catalyses the decarboxylation of both ~-3,4-dihydroxyphenylalanine and L-5-hydroxytryptophan (5-HTP) to form dopamine or serotonin (5-HT), respectively. The A A A D enzyme is present in many tissues (Rahman et ul., 1 9 8 1 ), but is particularly active in the kidney, where the products of decarboxylation (i.e. dopamine and 5-HT) are thought to affect renal haemodynamics directly. Dopamine causes marked natriuresis, diuresis, and dilatation of the renal vasculature, whereas 5-HT is thought to exert opposite effects (Stier et al., 1984) . Several previous studies have measured A A A D activity by incubating tissue homogenates with one of the enzyme substrates, followed either by direct measurement of the mass of product generated in the incubate, using high-pressure liquid chromatography coupled with electrochemical detection (Stier et al., 1987) or by measuring the amount of C 0 2 produced during the decarboxylation reaction (Clark et d., 1954) . Both techniques are time consuming, and therefore restrict the throughput of large numbers of samples. We have used a radioimmunoassay ( M A ) for 5-HT developed in our own laboratories (Gow et al., 1987) to measure the production in vitro of 5-HT from 5-HTP by isolated rat renal cortical cells (RCC). Female Wistar rats (200-250 g) were killed by cervical dislocation and the kidneys removed immediately into icecold physiological saline. The kidneys were trimmed of fat, the capsules removed, and the cortex dissected from the medulla. Intact RCC were prepared using the collagenase digestion procedure described by Drury et ul. (1986) , with modifications by Noble et al. (1988) . The cells were finally resuspended in Medium 199 containing bovine serum albumin ( 2 g/l).
For each experiment, aliquots (800 pl) of a freshly prepared RCC suspension containing 0.5 x 1 O6 cells/ml were dispensed in duplicate into glass tubes in an ice/water slurry (4"C), followed by Medium 199 (100 pl) containing both pargyline (final concentration 1 W 6 mol/l), and varying doses of 5-HTP ( O -l O -s mol/l, final concentration). A further aliquot of Medium 199 (100 p l ) or, for the inhibitor experiments, Medium 199 containing the A A A D inhibitor carbidopa (100 pl; lo-' mol/l, final concentration) was added, and the tubes incubated in a shaking water-bath (120 cycles/min) at 37°C for 30 min. The reaction was stopped by plunging the incubation tubes into an ice/water slurry, followed by centrifugation at 1720 g for 20 min at 4°C. The supernatants were then collected, and frozen at -20°C until analysis by RIA. Our results (Fig. 1) show a dose-dependent production of 5-HT by RCC in response to the increasing concentration of substrate (5-HTP). This response was significantly diminished ( P < 0.05, 2-way analysis of variance) by the inclusion of carbidopa ( l o -" mol/l) in the incubates and is in agreement with the observations of Stier & ltskovitz (1985) . We proposc that the analysis of A A A D activity in the kidney and other tissues by RIA will greatly simplify the methodology and enhance our understanding of an enzyme whose physiological role to date has received very little attention. This application of RIA for 5-HT provides a sensitive and technically straightforward method for the analysis of A A A D activity, and will allow far greater throughput of samples than the other methods used to measure the products of decarboxylation. The availability of purine ribonucleotidcs in specific tissues depends on local synthesis de tiovo and on the purine phosphoribosyltransferase-catalysed pyrophosphorylation of the free purine bases (purine salvage) as well as on purines transported in erythrocytes from other biosynthetic sites (Murray, 1971) . It has been suggested that the brain, testis and bone marrow are particularly dependent on the purine salvage pathway and that this explains the neurological manifestations, testicular atrophy and megaloblastic anaemia. The rate of purine synthesis de novo in the patients as a whole is accelerated (Seegmiller et al., 1967) . This implies increased synthesis de tiovo at the tissue level. However, there has been no direct evidence as to whether this could involve the organs and tissues generally or only some of them.
BIOCHEMICAL SOCIETY TRANSACTIONS
The present communication reports measurements of the activity of the purine synthesis pathway de novo in tissues from two patients with the Lesch-Nyhan syndrome, together with the activities of the purine phosphoribosyltransferase enzymes [HPRT and adenine phosphoribosyltransferase (APRT; EC 2.4.2.7)] in the same tissues. Table 1 shows the results of the purine synthesis de novo activity measurements. This pathway was active in all the tissues studied. As anticipated, there was no HPRT activity (assayed as described by Craft et al., 1970) . APRT activity (assayed as described by Dean et al., 1968) was present. The presence of purine synthesis de novo agrees with the previous report that amidophosphoribosyltransferase (EC 2.4.2.14), the first enzyme of the pathway, was present in the tissues of another Lesch-Nyhan syndrome patient (Watts et al., 1982) .
For clinical reasons, the tissues from the two patients could only be obtained 6 and 10 h after death, respectively. Control experiments with rat tissue showed that the purine synthesis activity de novo had decreased by about 30-50% of the time zero value by 12 h after death, whereas the HPRT and APRT activities were approximately constant over this time period. Therefore, the relative activities of the two pathways cannot bc compared directly. However, these results establish the presence of purine synthesis activity de novo directly in the Lesch-Nyhan syndrome patients' tissues generally. HPRT catalyses the pyrophosphorylation of Abbreviations used: HPRT, hypoxanthine phosphoribosyltransfcrase; A PRT, adcnine phosphoribosyltransferase. guanine to GMP as well as hypoxanthine to IMP. Guanine nucleotides are needed for a wide range of biochemical functions, including polynucleotide, protein, glycoprotein, cyclic GMP and pteridine synthesis. Pteridine availability could modulate neurotransmitter balance and this is disturbed in the Lesch-Nyhan syndrome. Watts (1985) reviewed the implications of the interrelationships of the purine and pteridine biosynthesis pathways for the possible pathogenesis of the Lesch-Nyhan syndrome. Evidence is also accumulating that, in the testis and adrenal cortex, maximal stimulation demands a lcvel of purine nucleotide synthesis which can only be achieved by purine salvage as well as synthesis de iiovo (Watts et a/., 1987) . Similar considerations may apply in the central nervous system, where bursts of increased neuronal activity produce peaks of purine requirements, which can only be fully met by purine salvage.
